For this International Day of Women and Girls in Science, we’re highlighting Dr. Donna Kimmaliardjuk, Faculty of Medicine alumna, and Canada’s first Inuk heart surgeon! 🧡🫀 After learning that amyotrophic lateral sclerosis (ALS) took her paternal grandfather’s life, preventing her from ever meeting him, she became determined to become a surgeon: “At six years old, I decided, ‘I want to be a surgeon. I want to invent a surgery to cure ALS.’” She would eventually shift her focus to cardiac surgery, and now works at the Cleveland Clinic, where she specializes in advanced coronary revascularization, coronary artery bypass grafting, and myectomy surgery—making her the first Inuk surgeon to practice in this specialty. Dr. Kimmaliardjuk’s story is an inspiration for women and girls pursuing science and medicine. Read more about her and her story ➡️ uottawa.ca/faculty-medicine/… @uOttawa @uOIndigenous

🆕 New in @JAMA_current 🧠🩸 Age-adjusted D-dimer works for DVT too! In a multinational prospective study (n=3,205), an age-adjusted cutoff safely ruled out DVT, increasing exclusions by 7.4% with 0% failures at 3 months. 📉 Fewer scans, same safety. jamanetwork.com/journals/jam…

🚨 Pregnancy-associated VTE & racial disparitiesat #ASH25 In a population study of 442,816 pregnancies, 1,793 VTEs occurred (4.0/1,000). Asian & Black individuals had lower VTE incidence (aRR 0.48 & 0.73) but more diagnostic delays higher acute-care use after VTE. 🩺 17-fold ↑ ED visits in week pre-diagnosis. @IMYanXu

Every ER doc in Canada - myself included - needs to listen to Rowan Hamilton's dad. This healthy 20-year old had SOB, tachycardia, blurry vision, cough of mucous and blood, normal CXR, d/c on ABx. The next day he collapsed with PEA and found with PEs. globalnews.ca/news/11543630/…

It’s #ASHCRTI week in LaJolla. @ASH_hematology A week full of redoing study proposals, mentorship and forming life long professional friendships for participants and faculty - 28 trainees across classical and malignant hematology #ASHTrainee

☀️ Nothing beats a brisk morning walk to kick off a packed day at #ASHCRTI! 🏃‍♂️💬 Great energy, great company, and even better conversations with fellow hematology enthusiasts. Thanks to everyone who joined us this morning – the perfect way to start learning and networking! 🙌 @ASH_hematology_edu

🩸 Meta-analysis presented at #ISTH2025 and simultaneously published in @ehj_ed found that several risk factors (e.g., previous history of VTE or bleeding, advanced cancer, and specific cancer sites) are associated with recurrent VTE and bleeding in patients with CAT. academic.oup.com/eurheartj/a…

🩸 Important findings from Dr @IMYanXu at #ISTH2025: Black individuals on extended anticoagulation for secondary VTE prevention had higher rates of major bleeding, including ICH, than White individuals. 🔎 No difference in CRNMB. 📢 Calls for action to address racial disparities.

Join us today at 11am ET for the next edition of our National Thrombosis Seminar series as we discuss "The NLRP3 Inflammasome and Interleukin-1 in Thromboinflammation and #VTE" Featuring: @NicolaPotereMD Register: buff.ly/4g04UHl #Thrombosis #Research

The University of Ottawa Faculty of Medicine is celebrating #BlackHistoryMonth, an important occasion to honour and celebrate the legacy of local and global black communities. ✊🏿✊🏾✊🏽 Stay tuned for interesting stories and events.

📢 Interested in navigating the complexities of #InclusiveCommunication in #Healthcare? The @EqHSLab invites healthcare professionals, educators, researchers, students, and health system leaders to the launch of its first book, Carefully Chosen Words—Language for Inclusive Care, tomorrow at 4 PM. Co-written by @uOttawaMed Dr. Jerry Maniate, this evidence-informed guide is a must-read! #InclusiveCare #HealthEquity

WEBINAR: Join us for the next edition of our National Thrombosis Seminar series on January 8th at 11 am ET on "Incorporating EDI in VTE Research Design and Implementation" ! Featuring: Shoba Dawson, MSc, PhD & Yan Xu, MD, MSc buff.ly/40kCrGz #VTE #Thrombosis

Rivaroxaban for 18 Months Superior to 6 Months To Prevent Recurrent VTE Events in Cancer Patients with Acute-low PE: ONCO PR Written by @JMKimMD! Summary, analysis and more AHA coverage below! cardiologynownews.org/rivaro… @CMichaelGibson

New @NEJM and #AHA2024 Left atrial appendage closure (Watchman device) randomized trial vs blood thinners after ablation for atrial fibrillation Significantly reduced major bleeding events and no increase in stroke, embolism or death by @omwazni and colleagues nejm.org/doi/full/10.1056/NE…

New study highlights how limited language proficiency hampers participation in #VTE #research. Addressing #language barriers is crucial to ensure all eligible patients have equal opportunities to contribute to and benefit from clinical studies #HealthEquity ✍️@IMYanXu @uOttawaMed @MarcCarrier1 @LanaCastellucci @DebSiegal @TzufeiWang @KimptonMiriam @lisa_duffett jthjournal.org/article/S1538…

Thanks @MathildeGSimard for being a guest on our most recent CSIM episode on planetary health! We're so excited to release Part 2 next week. @MedicinePods @CSIMSCMI @ChooseWiselyCA @WKSilverstein @OwenLuo5

We don't want you to miss this great learning and networking opportunity. Join us for our annual conference. Register today: bit.ly/3AeeK9b #Thrombosis #MedEd

Have you taken our global survey yet? If so, drop what country you're representing below⬇️. If not, click here for more info: WorldThrombosisDay.org/Surve… #WTDay24 #WorldThrombosisDay

As we continue our journey to reconciliation and uphold Indigenous Peoples' right to self-determination, the CMA invites organizations and individuals across the country to reflect on #NDTR and take meaningful steps forward. cma.ca/about-us/what-we-do/p…

Thank you @OntarioHealthOH OLMP, thank you @Dynacare, thank you @LifeLabs, thank you AlphaLabs, thank you @UofT, thank you to all members of ‘Raise the Bar’. This is a big step forward for Ontario and for 🇨🇦 Canada in promoting health equity for ppl with iron deficiency. 💥